Chemoinformaics analysis of 3-(3,5-DIHYDROXY-4-METHOXYPHENYL)-7-HYDROXYCHROMEN-4-ONE
| Molecular Weight | 300.266 | nRot | 2 |
| Heavy Atom Molecular Weight | 288.17 | nRig | 18 |
| Exact Molecular Weight | 300.063 | nRing | 3 |
| Solubility: LogS | -3.627 | nHRing | 1 |
| Solubility: LogP | 2.373 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 39.5335 |
| nHD | 3 | BPOL | 16.3785 |
| QED | 0.672 |
| Synth | 2.481 |
| Natural Product Likeliness | 1.171 |
| NR-PPAR-gamma | 0.322 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.973 |
| HIA | 0.008 |
| CACO-2 | -4.865 |
| MDCK | 0.0000104 |
| BBB | 0.018 |
| PPB | 0.950899 |
| VDSS | 0.493 |
| FU | 0.0479543 |
| CYP1A2-inh | 0.967 |
| CYP1A2-sub | 0.789 |
| CYP2c19-inh | 0.337 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.52 |
| CYP2c9-sub | 0.858 |
| CYP2d6-inh | 0.788 |
| CYP2d6-sub | 0.609 |
| CYP3a4-inh | 0.822 |
| CYP3a4-sub | 0.117 |
| CL | 7.031 |
| T12 | 0.905 |
| hERG | 0.045 |
| Ames | 0.054 |
| ROA | 0.339 |
| SkinSen | 0.936 |
| Carcinogencity | 0.178 |
| EI | 0.937 |
| Respiratory | 0.208 |
| NR-Aromatase | 0.73 |
| Antiviral | Yes |
| Prediction | 0.854686 |